Oncology Nutrition Market Size (2024 - 2029)

The oncology nutrition market is anticipated to experience growth over the forecast period, driven by the increasing prevalence of cancer and the introduction of new nutritional products. The COVID-19 pandemic highlighted the importance of nutrition in managing cancer patients, leading to a demand for tailored nutritional protocols. Government and private sector awareness initiatives have further fueled market expansion, as they emphasize the role of diet in cancer treatment and recovery. Despite these growth drivers, the high cost of premium oncology nutrition products poses a challenge to market expansion.

Market Size of Oncology Nutrition Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Oncology Nutrition Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 8.90 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Oncology Nutrition Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Oncology Nutrition Market Analysis

Over the next few years, the oncology nutrition market is expected to grow at an annual rate of 8.9%.

The COVID-19 pandemic turned the spotlight on the oncology nutrition market, though the healthcare systems have been significantly impacted. For instance, the study published by Nutrition and Cancer in May 2021 focused on creating recommendations on the nutritional protocol for the management and prevention of complications during the COVID-19 pandemic for all cancer patients. Patients with cancer are more susceptible to illnesses due to either direct immune system impairment or anticancer medication. Furthermore, as per the article published by the National Library of Medicine in June 2021, the role of nutrition, dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 phase, as well as the value of diet in the susceptibility, prevention, and management of COVID-19 in cancer patients, The COVID-19 pandemic demanded the development of nutritional maintenance and complication control recommendations for all cancer patients, according to the same source. However, the market was gradually stabilizing as COVID-19 cases declined, resulting in the return of normal demand levels for oncology nutrition. Thus, COVID-19 was expected to have a significant impact on the oncology nutrition market over the forecast period.

The major factors contributing to the growth of the oncology nutrition market are the rising prevalence of cancer worldwide and the introduction of new oncology nutrition products. According to a BioMed Central Ltd article published in April 2022, the number of new cancer cases in Germany is expected to rise by 20% by 2030.Additionally, according to the AACR Cancer Progress Report 2022, in the past three years, the number of cancer survivors living in the United States has increased by more than a million, reaching more than 18 million as of January 1, 2022. The use of nutritional products during and after the treatment of cancer gives the ability to fight disease and offers strength and stamina against the treatment's after-effects, which is driving the market's growth.

Furthermore, the awareness provided by the government and private agencies is one of the main fueling factors for market growth. For instance, as per the 2022 update from the American Society of Clinical Oncology (ASCO) Cancer.Net, after cancer treatment is complete, most experts recommend a healthy diet that includes plenty of fruits, vegetables, and whole grains. Furthermore, according to the Agency for Healthcare Research and Quality, the prevalence of malnutrition among adults with cancer is high in October 2021, with estimates ranging from 25% to 80% across patient populations.This increase in malnutrition among cancer patients is expected to increase the demand for oncology nutrition, thus boosting market growth over the forecast period.

Hence, as per the aforementioned factors, the oncology nutrition market is likely to grow over the forecast period. However, the high cost of premium nutrition products for oncology restrains the market's growth.

Oncology Nutrition Industry Segmentation

As per the scope of the report, oncology nutrition is a vital part of the entire process of recovering from cancer. Consuming a wide variety of foods and nutritious meals helps in coping with the heavy medication that is a part of cancer treatment. Following well-balanced oncology, nutrition helps in improving strength, maintaining body weight, and assisting the body in recovering from cancer. The oncology nutrition market is segmented by cancer type (head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and other cancers), end user (hospitals, home care, and others), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Cancer Type
Head & Neck Cancer
Stomach & Gastrointestinal Cancers
Blood Cancer
Breast Cancer
Lung Cancer
Other Cancers
By End-User
Hospitals
Home Care
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Oncology Nutrition Market Size Summary

The oncology nutrition market is poised for significant growth, driven by the increasing prevalence of cancer globally and the introduction of innovative nutrition products tailored for cancer patients. The COVID-19 pandemic highlighted the critical role of nutrition in managing and preventing complications in cancer patients, as they are more vulnerable to infections due to compromised immune systems. This awareness has spurred demand for oncology nutrition, as it plays a vital role in supporting patients during and after cancer treatment, helping them regain strength and stamina. Government and private sector initiatives, such as the American Society of Clinical Oncology's dietary recommendations and the Agency for Healthcare Research and Quality's focus on malnutrition, are further propelling market expansion by raising awareness and encouraging the adoption of nutritional supplements among cancer patients.

North America is expected to experience robust growth in the oncology nutrition market, supported by advanced healthcare infrastructure and a high incidence of cancer cases. The region benefits from numerous government initiatives, product launches, and collaborations aimed at enhancing cancer nutrition. Educational programs and certification courses, such as those offered by the Oncology Nutrition Institute, are also contributing to market growth by equipping healthcare professionals with the knowledge to support cancer patients through nutrition. The market is characterized by a consolidated landscape, with key players like Abbott Laboratories, Nestle, and Fresenius Kabi AG leading the charge. Recent developments, such as Nestle's launch of specialized medical foods in China and Faeth Therapeutics' funding for clinical trials, underscore the dynamic nature of the market and its potential for continued expansion.

Explore More

Oncology Nutrition Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising prevalence of Cancer Worldwide

      2. 1.2.2 Introduction of New Oncology Nutrition Products

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Premium Nutrition Products for Oncology

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Cancer Type

      1. 2.1.1 Head & Neck Cancer

      2. 2.1.2 Stomach & Gastrointestinal Cancers

      3. 2.1.3 Blood Cancer

      4. 2.1.4 Breast Cancer

      5. 2.1.5 Lung Cancer

      6. 2.1.6 Other Cancers

    2. 2.2 By End-User

      1. 2.2.1 Hospitals

      2. 2.2.2 Home Care

      3. 2.2.3 Other End-Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Oncology Nutrition Market Size FAQs

The Oncology Nutrition Market is projected to register a CAGR of 8.90% during the forecast period (2024-2029)

Abbott Laboratories, Fresenius Kabi AG, Hormel Foods Corporation (Hormel Health Labs), Nestlé and B. Braun SE are the major companies operating in the Oncology Nutrition Market.

Oncology Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)